Navigation Links
Merck and Takeda to collaborate in the sale of Cancer drug Matuzumab

Merck Pharmaceuticals from Germany and Takeda Pharmaceuticals from Japan to colloborate in marketing of Merck's cancer drug Matuzumab.

Matuzumab is developed by Merck which is in its Phase II // clinical tiral. Takeda Pharmaceuticals will sign agreement with Merck to give royalty and sale benefits from the sale of Matuzumba. Takeda will pay 60 million euros to Merck with an addition of royalty.

"Merck KGaA and Takeda Pharmaceutical have entered into a co-development and co-commercialization agreement for Merck's Matuzumab," the German company said in a statement.

Matuzumab was developed by Merck and currently is in Phase II clinical trials in patients with lung, gastric and colorectal cancers. Merck said it had decided to enter into cooperation with Takeda "in order to put more resources and expertise toward this important product". "Takedas experience and commitment in the field of oncology makes it a perfect fit with Merck, " it said.

"This collaboration with Takeda, Japans largest pharmaceutical company, will allow us to move ahead quickly with development and commercialisation of this potentially important product for cancer patients," said the head of Merck Ethical Pharmaceuticals, Elmar Schnee.

Source: Indo-Asian News Services
'"/>




Page: 1

Related medicine news :

1. E Merck introduces Livogen Z with zinc sulphate
2. Merck to pay $ 253.5 million to Vioxx victim family
3. Judgment In Favor Of Merck For Vioxx Drug
4. Merck, ICMR to conduct joint trials on cervical cancer vaccine
5. Merck in the Dock Due To Vioxx
6. Merck Says Januvia Effective In Type 2 Diabetes
7. Dr Reddys Launches Generic Version Of Mercks Proscar Tablets
8. Patency On Two Drugs From Merck & Pfizer’s To Expire Soo
9. Developing Nations to Get Gardasil at Lesser Rates from Merck Soon
10. Acid Test - Glaxos Cervarix, and Mercks Gardasil, Compete
11. Ranbaxy in Fray to Buy Mercks Generic Drugs Unit

Post Your Comments:
(Date:11/27/2009)... KELOWNA,BC,Nov.27/PRNewswire/-UploadableUSBpedome...lness.Acombinationofadvancedaccelerometerfunctiona...rnovertheaccuracyofself-reporteddata.It,snowpossib...nafitnessprogram. ,, CoreHealthTechnologiesison...ogy."Ourhealthchallengesareeasytoadministerandpart...
(Date:11/27/2009)... ROCHESTER,N.Y.,Nov.27/PRNewswire-USNewswire/--Pre...dfortunatelyeveryyear,newvaccinesarebeingaddedtoas...ityforthesameperiodoftime?And,ifnot,whenareadditio... Inthismonth,sissueofPediatrics,theJournaloftheAme...toroftheRochesterGeneralResearchInstitute,basedatR...
(Date:11/27/2009)... and cycling plus low-emission vehicles may reduce... , FRIDAY, Nov. 27 (HealthDay News) -- Encouragin...ng cars would offer much greater public health ben..., U.K. researchers have found. , The study comp...native urban land transport scenarios for London, ...
(Date:11/27/2009)... Multi-purpose bilingual colorin...ed for use by the business community to educate - ...subjects from Safety issues to Dinosuars to ABC,S ... Saint Louis, MO (PRWEB) November 27, 2009 -- ...onics or toys to keep them busy any hour of the da...
(Date:11/26/2009)... PRINCETON,N.J.,Nov.27/PRNewswire/--Thediabetespop...t25yearsandannualmedicalspendingonthediseaseisproj...dingtoastudypublishedintheDecemberissueof Diabetes...CDP),aprogramofNovoNordisk,commissionedtheanalysis...totheforecast,thenumberofAmericanslivingwithdiabet...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3
...iott Yamin To Perform, LOS ANGELES, Sept. 11 Ope...ty dedicated to helping improve the health and,liv...Lopez, American Idol:,"Idol Gives Back" and Vicky ...ett Family. "E! News" host Giuliana Rancic,emcees ...
...YANG, China, Sept. 11 /Xinhua-PRNewswire-FirstCall...C Bulletin Board: GNPH) ("Genesis" or,the "Company...,s Republic,of China, today announced that the Com...Annual New Drugs Conference (the,"Conference") spo...
... American Podiatric Medical...eventative tips. , Bethes...-09 football season still in its fledgling stages,...ing back for the Ohio State University Buckeyes, c...
...T WORTH, Texas, Sept. 11 Wound Management,Technol... today its,strategic plans for the remainder of th... on bringing the science and technology to the mar...rking,with several major medical groups, physician...
...CLEMSON Black lung disease is not a problem of th...to die from it and associated ailments. , In resp...arded John R. Saylor, associate professor of mecha...lor,s research focuses on a combination of water s...
...rnal of Nutrition Cites Almonds as a Rich Source t...re than 90,percent of the U.S. population does not...n E, according to a special supplement to the,Sept...concluded that vitamin E, among other things, can ...
Other Medicine News:Health News:Operation Smile to Honor Mario Lopez, American Idol: 'Idol Gives Back,' Roma Downey & Mark Burnett Family and Vicky Mense at Smile Gala in Los Angeles 2Health News:Genesis Pharmaceuticals Received New Purchase Orders Worth $12 Million 2Health News:Genesis Pharmaceuticals Received New Purchase Orders Worth $12 Million 3Health News:Foot Injuries Plague Athletes During Fall Sports Season 2Health News:Foot Injuries Plague Athletes During Fall Sports Season 3Health News:Wound Management Technologies, Inc. Announces Strategic Plans for Revenue Growth for Year End and 2009 2Health News:CDC awards Clemson researcher $700,000 to study black lung prevention 2Health News:E-mergency? Majority of U.S. Consumers Lack Essential Vitamin E 2
(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/--Reportlinker.co...nitscatalogue: ,, UnitedStatesDentalDevicesMar...eportlinker.com/p0158733/United-States-Dental-Devi..., UnitedStatesDentalDevicesMarketAnalysisandFore...sentialsourceforin-depthinformationanddatarelating...
(Date:11/25/2009)..., SANDIEGO,Nov.25/PRNewswire-FirstCall/--NuVa...sedondevelopingproductsforminimallydisruptivesurgi...ostaconferencecallonMonday,November30,2009,at5:30p...ntissuesrelativetoreimbursementfortheCompany,sprod...ashortquestionandanswersession.Thedial-innumbersar...
(Date:11/25/2009)..., FRAMINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire...TWR ;ASX:HIN),aleadinginnovatorandprovideroflessin...evolutionizingthetreatmentofadvancedheartfailure,t...entationatthe21stAnnualPiperJaffrayHealthCareConfe...erenceisbeingheldattheNewYorkPalaceHotel,December1...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Linkwell Corporation Announces Launch of the Series of Handwashing Contest Across China 55285 1Linkwell Corporation Announces Launch of the Series of Handwashing Contest Across China 55285 2Linkwell Corporation Announces Launch of the Series of Handwashing Contest Across China 55285 3B Braun Named Supplier of the Year by McKesson 55284 1B Braun Named Supplier of the Year by McKesson 55284 2Hospice Foundation of America Presents New Educational Webinar on Supporting People with Intellectual Disabilities through Illness Grief and Loss 55282 1Hospice Foundation of America Presents New Educational Webinar on Supporting People with Intellectual Disabilities through Illness Grief and Loss 55282 2Hospice Foundation of America Presents New Educational Webinar on Supporting People with Intellectual Disabilities through Illness Grief and Loss 55282 3
... Interim analysis of Phase 2 comparative study sho...rsus Rebif, CAMBRIDGE, Mass. and WAYNE, N.J., May ...tion and Bayer HealthCare,Pharmaceutical today ann...Phase 2 study. This interim analysis of all patien...e start of the study for,all patients showed that ...
... HAMBURG, Germany, May 03, 2007 /PRNewswire/ -- A...ed data which provide a sound,scientific basis for... in patients. , Tumor tissue-derived primary cell ...ug testing. During their clonal selection and,expa...patterns,change significantly, thereby losing many...
Other Medicine Technology:Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 2Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 3Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 4Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 5Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 6Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 7Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 8Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 9Indivumed Study Provides Sound Scientific Basis for a Predictive,Drug Test- Platform 2
Eppendorf Research Series 2100 Adjustable-volume Pipette, 20-200 l
...or for sub-microliter pipetting and beyond. Offers...adjustable. Features lPLUS, a direct-drive digital...le ejector buttons to fit large hands or tiny hand...ifferent lengths. Air-displacement mechanism. No r...
...bsystems was designed specifically to combine ergo...features such as the new fast dial system with .01...define this as a new leader in single channel pipe...a custom fit for different hand sizes. The new sho...
...tte is a synonym for pipetting accuracy, a smooth ...operating comfort. Its single, multifunctional but...ow-out as well as eject the tip. Product features...ccuracy and precision. Ejection sleeve can be rem...
Medicine Products: